trial

Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders

NCTId NCT01081418
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 120 (actual)
Sponsored by Universitätsklinikum Hamburg-Eppendorf
Primary completion 2008-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
120 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2005-04
Primary completion
2008-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Assertive Community Treatment (ACT)

Sponsors

Universitätsklinikum Hamburg-EppendorfLead Sponsor

Investigators

1
Martin Lambert, ProfessorPrincipal Investigator

Sites

1 total
Hamburg, Germany

Facts & assertions

4 sourced
Enrollment
120
Phase
PHASE4
Primary Completion Date
2008-12
Status
COMPLETED
relationships
The graph out of here
drug
Assertive Community Treatment (ACT)
drug
lead_sponsor
Universitätsklinikum Hamburg-Eppendorf
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Martin Lambert, Professor
person